LUMOS PHARMA, INC. Insider Trading for January 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LUMOS PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LUMOS PHARMA, INC. for January 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 23 2014 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Sell | S | 34.81 | 3,586 | 124,833 | 3,429 | 7 K to 3.4 K (-51.12 %) |
| Jan 23 2014 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Sell | S | 34.81 | 3,587 | 124,868 | 3,429 | 7 K to 3.4 K (-51.13 %) |
| Jan 23 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | M | 11.79 | 5,000 | 58,950 | 169,000 | |
| Jan 23 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | M | 11.79 | 10,000 | 117,900 | 174,000 | |
| Jan 23 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 35.64 | 5,000 | 178,198 | 6,826 | 11.8 K to 6.8 K (-42.28 %) |
| Jan 23 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Buy | M | 11.79 | 5,000 | 58,950 | 11,826 | 6.8 K to 11.8 K (+73.25 %) |
| Jan 23 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 35.01 | 10,000 | 350,083 | 6,826 | 16.8 K to 6.8 K (-59.43 %) |
| Jan 23 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Buy | M | 11.79 | 10,000 | 117,900 | 16,826 | 6.8 K to 16.8 K (+146.50 %) |
| Jan 17 2014 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Sell | S | 29.95 | 1,414 | 42,349 | 7,015 | 8.4 K to 7 K (-16.78 %) |
| Jan 17 2014 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Sell | S | 29.95 | 1,413 | 42,319 | 7,016 | 8.4 K to 7 K (-16.76 %) |
| Jan 17 2014 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Gift | G | 0.00 | 1,200 | 0 | 2,500 | 1.3 K to 2.5 K (+92.31 %) |
| Jan 17 2014 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Gift | G | 0.00 | 2,400 | 0 | 62,391 | 64.8 K to 62.4 K (-3.70 %) |
| Jan 17 2014 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Option Exercise | M | 3.07 | 30,000 | 92,100 | 11,428 | |
| Jan 17 2014 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Sell | S | 30.00 | 30,000 | 900,000 | 33,064 | 63.1 K to 33.1 K (-47.57 %) |
| Jan 17 2014 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Buy | M | 3.07 | 30,000 | 92,100 | 63,064 | 33.1 K to 63.1 K (+90.73 %) |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | M | 2.10 | 18,664 | 39,194 | 290,374 | |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 26.58 | 18,664 | 496,033 | 64,144 | 82.8 K to 64.1 K (-22.54 %) |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Buy | M | 2.10 | 18,664 | 39,194 | 82,808 | 64.1 K to 82.8 K (+29.10 %) |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 26.58 | 16,336 | 434,162 | 64,144 | 80.5 K to 64.1 K (-20.30 %) |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 26.00 | 10,000 | 260,000 | 80,480 | 90.5 K to 80.5 K (-11.05 %) |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | M | 11.79 | 10,000 | 117,900 | 184,000 | |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | M | 11.79 | 10,000 | 117,900 | 194,000 | |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 30.00 | 10,000 | 300,000 | 6,826 | 16.8 K to 6.8 K (-59.43 %) |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Buy | M | 11.79 | 10,000 | 117,900 | 16,826 | 6.8 K to 16.8 K (+146.50 %) |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 25.18 | 10,000 | 251,838 | 6,826 | 16.8 K to 6.8 K (-59.43 %) |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Buy | M | 11.79 | 10,000 | 117,900 | 16,826 | 6.8 K to 16.8 K (+146.50 %) |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 30.05 | 25,000 | 751,250 | 810,818 | 835.8 K to 810.8 K (-2.99 %) |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 25.36 | 25,000 | 634,090 | 835,818 | 860.8 K to 835.8 K (-2.90 %) |
| Jan 09 2014 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Option Exercise | M | 2.10 | 500 | 1,050 | 65,239 | |
| Jan 09 2014 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Sell | S | 22.55 | 453 | 10,215 | 14,213 | 14.7 K to 14.2 K (-3.09 %) |
| Jan 09 2014 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Payment of Exercise | F | 22.55 | 47 | 1,060 | 14,666 | 14.7 K to 14.7 K (-0.32 %) |
| Jan 09 2014 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Buy | M | 2.10 | 500 | 1,050 | 14,713 | 14.2 K to 14.7 K (+3.52 %) |
| Jan 07 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | M | 2.10 | 4,635 | 9,734 | 309,038 | |
| Jan 07 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | M | 2.10 | 25,322 | 53,176 | 43 | |
| Jan 07 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | M | 0.80 | 43 | 34 | 2,521 | |
| Jan 07 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 22.19 | 4,196 | 93,113 | 93,644 | 97.8 K to 93.6 K (-4.29 %) |
| Jan 07 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Payment of Exercise | F | 22.19 | 439 | 9,742 | 97,840 | 98.3 K to 97.8 K (-0.45 %) |
| Jan 07 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Buy | M | 2.10 | 4,635 | 9,734 | 98,279 | 93.6 K to 98.3 K (+4.95 %) |
| Jan 07 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 22.19 | 22,925 | 508,724 | 93,644 | 116.6 K to 93.6 K (-19.67 %) |
| Jan 07 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Payment of Exercise | F | 22.19 | 2,397 | 53,191 | 116,569 | 119 K to 116.6 K (-2.01 %) |
| Jan 07 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Buy | M | 2.10 | 25,322 | 53,176 | 118,966 | 93.6 K to 119 K (+27.04 %) |
| Jan 07 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 22.19 | 41 | 910 | 93,644 | 93.7 K to 93.6 K (-0.04 %) |
| Jan 07 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Payment of Exercise | F | 22.19 | 2 | 44 | 93,685 | 93.7 K to 93.7 K (0.00 %) |
| Jan 07 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Buy | M | 0.80 | 43 | 34 | 93,687 | 93.6 K to 93.7 K (+0.05 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Grant | A | 0.00 | 3,000 | 0 | 59,715 | 56.7 K to 59.7 K (+5.29 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Option Exercise | A | 21.38 | 27,000 | 577,260 | 27,000 | |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Grant | A | 0.00 | 5,700 | 0 | 14,213 | 8.5 K to 14.2 K (+66.96 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Option Exercise | A | 21.38 | 108,750 | 2,325,075 | 108,750 | |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 22.44 | 9,000 | 201,915 | 864,987 | 874 K to 865 K (-1.03 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 21.97 | 11,000 | 241,626 | 873,987 | 885 K to 874 K (-1.24 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Grant | A | 0.00 | 23,000 | 0 | 884,987 | 862 K to 885 K (+2.67 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Grant | A | 0.00 | 12,500 | 0 | 861,987 | 849.5 K to 862 K (+1.47 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Grant | A | 0.00 | 3,000 | 0 | 26,380 | 23.4 K to 26.4 K (+12.83 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | A | 21.38 | 71,250 | 1,523,325 | 71,250 | |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Grant | A | 0.00 | 15,000 | 0 | 93,644 | 78.6 K to 93.6 K (+19.07 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Grant | A | 0.00 | 9,500 | 0 | 78,644 | 69.1 K to 78.6 K (+13.74 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | A | 21.38 | 27,000 | 577,260 | 27,000 | |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Grant | A | 0.00 | 5,700 | 0 | 6,826 | 1.1 K to 6.8 K (+506.22 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Option Exercise | A | 21.38 | 27,000 | 577,260 | 27,000 | |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Grant | A | 0.00 | 5,700 | 0 | 64,791 | 59.1 K to 64.8 K (+9.65 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Saluri Joseph | Director | Grant | A | 0.00 | 3,000 | 0 | 11,142 | 8.1 K to 11.1 K (+36.85 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Option Exercise | M | 3.07 | 10,000 | 30,700 | 41,428 | |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Option Exercise | A | 21.38 | 32,250 | 689,505 | 32,250 | |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Sell | S | 22.00 | 8,604 | 189,288 | 33,064 | 41.7 K to 33.1 K (-20.65 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Payment of Exercise | F | 22.00 | 1,396 | 30,712 | 41,668 | 43.1 K to 41.7 K (-3.24 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Buy | M | 3.07 | 10,000 | 30,700 | 43,064 | 33.1 K to 43.1 K (+30.24 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Grant | A | 0.00 | 6,800 | 0 | 33,064 | 26.3 K to 33.1 K (+25.89 %) |